| Trial ID: | L3828 |
| Source ID: | NCT02026310
|
| Associated Drug: |
Glimepiride
|
| Title: |
Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: glimepiride|DRUG: glargine and metformin
|
| Outcome Measures: |
Primary: 24 weeks after treatment, HbA1c values' change compared with baseline, 24 weeks after treatment | Secondary: hypoglycemia events, 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Qifu Li
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
40
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-01
|
| Completion Date: |
2015-12
|
| Results First Posted: |
|
| Last Update Posted: |
2016-01-28
|
| Locations: |
The First Affiliated Hospital of Chongqing Medical University, Chongqing,, Chongqing, 400016, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02026310
|
